Pursuing next-gen precision neurotherapeutics and innovative early interventions
Transform the lives of patients with neurological conditions

Focused on novel, neuroprotective compounds that restore neuronal function, PurMinds develops innovative disease-modifying therapeutics for patients with neurological disorders. We leverage proven mechanisms of action and next-generation neuroplastogens to stimulate neuroplasticity, reduce neuro-inflammation, and promote neuro-rejuvenation. Our NeuroLabs have conducted extensive research under a Health Canada-issued license for controlled drugs and substances, including a proprietary botanical Psilocybin program.

In addition to our therapeutic programs, PurMinds is advancing the future of precision medicine through developing next-generation diagnostic solutions aimed to identify diseases at their earliest and most treatable stages. By integrating biomarker intelligence and multi-omics data into portable point-of-care solutions, PurMinds’ platform empowers clinicians to identify diseases at their earliest, most treatable stages. This data-driven approach transforms healthcare from reactive to proactive—supporting timely, personalized decisions that improve outcomes, reduce costs, and enhance quality of life for patients worldwide.